HAX1 and colorectal carcinoma: Further, proteasome inhibitor MG132 was able to restore HAX1 protein level in CRC cells with EIF3H knockdown (Fig. 2e), indicating that EIF3H-mediated HAX1 expression was involved in proteasome-dependent mechanism.